Therapeutic Goods Regulatory Reforms target false and misleading industry practices – August 2009

The Federal Government is currently implementing a three-stage reform program to update the therapeutic goods regulatory framework in Australia. This legal update provides an overview of the amendments to the Therapeutic Goods Act 1989 and how they will have significant consequences for the pharmaceutical industry, particularly in relation to penalties for providing false or misleading patent certificates and stricter advertising regulations [read more].